CSIMarket
 


Lipocine Inc   (LPCN)
Other Ticker:  
 
 

LPCN's Revenue Growth by Quarter and Year

Lipocine Inc 's Revenue results by quarter and year




LPCN Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.09 0.03 15.58 0.13
III Quarter September -3.12 0.33 0.53 0.14
II Quarter June 0.03 1.08 0.22 -2.07
I Quarter March 0.15 -0.38 -0.20 -1.10
FY   -2.85 1.06 16.13 -2.90



LPCN Revenue fourth quarter 2023 Y/Y Growth Comment
Lipocine Inc reported Revenue surge of 202% year on year in the fourth quarter 2023, to $ 0.09 millions, this is lower than Lipocine Inc 's recent average Revenue surge of 1003.08%.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 89 other companies have achieved higher Revenue growth. While Lipocine Inc ' s Revenue doubling of 202% ranks overall at the positon no. 2014 in the fourth quarter 2023.




LPCN Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 202 % -99.81 % 11884.62 % 85.71 %
III Quarter September - -37.74 % 278.57 % -12.5 %
II Quarter June -97.22 % 390.91 % - -
I Quarter March - - - -
FY   - -93.43 % - -

Financial Statements
Lipocine Inc 's fourth quarter 2023 Revenue $ 0.09 millions LPCN's Income Statement
Lipocine Inc 's fourth quarter 2022 Revenue $ 0.03 millions Quarterly LPCN's Income Statement
New: More LPCN's historic Revenue Growth >>


LPCN Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -90.91 % 2839.62 % -7.14 %
III Quarter September - -69.44 % 140.91 % -
II Quarter June -80 % - - -
I Quarter March 400 % - - -
FY (Year on Year)   - -93.43 % - -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #90
Healthcare Sector #244
Overall #2014

Revenue Y/Y Growth Statistics
High Average Low
5496.57 % 1003.08 % -367.45 %
(Jun 30 2022)   (Dec 31 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #90
Healthcare Sector #244
Overall #2014
Revenue Y/Y Growth Statistics
High Average Low
5496.57 % 1003.08 % -367.45 %
(Jun 30 2022)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Lipocine Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LPCN's IV. Quarter Q/Q Revenue Comment
Improvement IV. Quarter 2023where Lipocine Inc published Revenue of $ 0.09 millions may is inception of improved business climet.Lipocine Inc announced in the IV. Quarter 2023 Revenue of $ 0.09 millions compare to recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Lipocine Inc achieved highest sequential Revenue growth. While Lipocine Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LPCN's IV. Quarter Q/Q Revenue Comment
This reversal of fortune IV. Quarter 2023where Lipocine Inc posted Revenue of $ 0.09 millions could be considered as a starting point of improved performance.Lipocine Inc announced in the IV. Quarter 2023 Revenue of $ 0.09 millions compare to recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Lipocine Inc achieved highest sequential Revenue growth. While Lipocine Inc 's Revenue growth quarter on quarter, overall rank is .


Lipocine Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ -2.85 $ -2.91 $ 0.54 $ 1.60 $ 1.07
Y / Y Revenue Growth (TTM) - - -96.78 % -89.99 % -93.4 %
Year on Year Revenue Growth Overall Ranking # 2014 # 16 # 7 # 16 # 4
Seqeuential Revenue Change (TTM) - - -66.12 % 49.83 % -93.58 %
Seq. Revenue Growth (TTM) Overall Ranking # 2014 # 2338 # 1881 # 30 # 92




Cumulative Revenue growth Comment
Lipocine Inc realized trailing twelve months of $ -3 millions, in the Dec 31 2023, compare to Revenue of $ 1 millions a year ago.

In the Healthcare sector 243 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 16 to 2014.

Revenue TTM Q/Q Growth Statistics
High Average Low
5496.57 %
1003.08 %
-367.45 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 90
Healthcare Sector # 244
Overall # 2014

Revenue TTM Y/Y Growth Statistics
High Average Low
5496.57 %
1003.08 %
-367.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 90
Sector # 244
S&P 500 # 2014
Cumulative Revenue growth Comment
Lipocine Inc realized trailing twelve months of $ -3 millions, in the Dec 31 2023, compare to Revenue of $ 1 millions a year ago.

In the Healthcare sector 243 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 16 to 2014.

Revenue TTM Q/Q Growth Statistics
High Average Low
5496.57 %
1003.08 %
-367.45 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 90
Healthcare Sector # 244
Overall # 2014

Revenue TTM Y/Y Growth Statistics
High Average Low
5496.57 %
1003.08 %
-367.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 90
Sector # 244
S&P 500 # 2014




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LPCN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LPCN's Competitors
Revenue Growth for Lipocine Inc 's Suppliers
Revenue Growth for LPCN's Customers

You may also want to know
LPCN's Annual Growth Rates LPCN's Profitability Ratios LPCN's Asset Turnover Ratio LPCN's Dividend Growth
LPCN's Roe LPCN's Valuation Ratios LPCN's Financial Strength Ratios LPCN's Dividend Payout Ratio
LPCN's Roa LPCN's Inventory Turnover Ratio LPCN's Growth Rates LPCN's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Ovid Therapeutics Inc 205.88%$ 205.884 millions
Argenx se191.46%$ 191.457 millions
Lipocine Inc 164.58%$ 164.577 millions
Blueprint Medicines Corporation163.28%$ 163.282 millions
Celldex Therapeutics inc 156.11%$ 156.107 millions
Intelgenx Technologies Corp 141.04%$ 141.040 millions
Co diagnostics Inc 140.48%$ 140.476 millions
Aclaris Therapeutics Inc 126.62%$ 126.622 millions
Globus Medical Inc 124.60%$ 124.604 millions
Sanuwave Health Inc 124.26%$ 124.259 millions
Roivant Sciences Ltd 117.80%$ 117.804 millions
Intelligent Bio Solutions Inc 114.22%$ 114.216 millions
Pacific Biosciences Of California Inc 113.62%$ 113.622 millions
Docgo Inc 112.37%$ 112.366 millions
Ionis Pharmaceuticals Inc112.32%$ 112.319 millions
Encompass Health Corporation109.55%$ 109.546 millions
Xencor Inc106.80%$ 106.798 millions
Volitionrx Limited103.79%$ 103.795 millions
Innovative Eyewear Inc 103.16%$ 103.159 millions
Coherus Biosciences inc 101.81%$ 101.808 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com